He has no conflicts of interest pertaining to Ozempic or either GLP-1s
While Semaglutide can offer substantial benefits for weight management and metabolic health, there are certain contraindications, such as allergies to its components, a history of certain medical conditions like pancreatitis, liver and kidney issues, history of thyroid carcinoma, or pregnancy
Last reviewed: 18 Jun 2026 Sources Wegovy tablet, emc [accessed 18 June 2026] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial, The Lancet [accessed 10 June 2026] Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity, The New England Journal of Medicine [accessed 10 June 2026] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen, emc [accessed 10 June 2026] Wegovy 1.5 mg tablets SmPC/PIL, emc [accessed 18 June 2026] Related weight loss treatments Further reading on Wegovy pill Trusted by thousands Your health guided by experts Our doctors are regulated by the CQC and GPhC, the same bodies overseeing NHS care.
in contrast, no risk reduction was observed for haemorrhagic stroke
